Group Sustainable Development Policy
PDF | 227.29 KB
The Mediclinic Group is committed to being a good corporate citizen and believes that sustainability must be integrated in its business strategy, focusing not only on its financial output, but also on managing and utilising social and environmental resources efficiently to ensure a sustainable business in the long term.
Mediclinic’s track record on delivering growth and creating long-term value in all its business operations in Southern Africa, Switzerland and the UAE is testament to its strategy of being a long-term player and delivering a sustainable business. While growth, profitability and creating shareholder value are certainly major strategic drivers, this cannot be achieved unless the Group offers efficient, effective, appropriate and evidence-based clinical services to its patients; follows ethical business practices, values its employees by following fair labour practices and offering competitive remuneration, training and development opportunities; respects the communities within which the Group operates and contributes to the well-being of society; and carefully manages its impact on the environment by focusing on its carbon footprint, use of energy and water resources and waste management.
Through the Group’s sustainability efforts Mediclinic believes that it will:
The Group Sustainable Development Policy, Group Environmental Policy and Code of Business Conduct and Ethics codify Mediclinic’s commitment to conducting business responsibly, which are reviewed annually.
The following material sustainability issues have been identified and are addressed in the Sustainable Development Report published annually and available in the Investor Relations section of the website:
Reports on the Group’s sustainable development and corporate social responsibility are published annually with the annual report. Please visit the Investor Relations section for the latest and previous reports.
The Group’s operations in South Africa, Mediclinic Southern Africa, forms an integral part of the political, social and economic community in South Africa and is committed to sustainable transformation as part of its business strategy. Mediclinic Southern Africa’s Executive Committee is responsible to ensure that the appropriate focus is placed on the group’s commitment to the development and implementation of sustainable broad-based black economic empowerment (“B-BBEE”) initiatives.
Mediclinic does not tolerate any form of human rights violation, including slavery and human trafficking, in its business or indirectly through its supply chain and is committed to ensuring that there is no slavery or human trafficking in our supply chain or in any part of our business.
For each financial year, the Board of Mediclinic issues a statement in terms of Section 54 of the Modern Slavery Act 2015 reporting on the steps taken during the year to ensure that slavery and human trafficking is not taking place.
We value your opinion and invite you to take a few minutes of your time to complete this survey giving feedback on Mediclinic's sustainable development reports and initiatives. Please download the form and send us your feedback through any of the options indicated on the form.